Hims & Hers Health Faces Securities Class Action Lawsuit, Investor Deadline Looms
Telehealth provider Hims & Hers Health is facing a securities class action lawsuit. Investors who incurred losses exceeding $100,000 have a deadline of November 2, 2026, to file lead plaintiff applications.
Hims & Hers Health, Inc. (NYSE: HIMS), a telehealth services company, is the subject of a securities class action lawsuit. Investors who purchased or acquired the company's securities between August 4, 2025, and July 29, 2026, are being notified of the deadline to apply as lead plaintiff.
The deadline to file lead plaintiff applications is November 2, 2026. The action is pending in the United States District Court for the Northern District of California. ClaimsFiler, a shareholder information service, is disseminating this notice to investors.
The lawsuit alleges that Hims & Hers Health and certain of its executives failed to disclose material information, violating federal securities laws. This specifically relates to a lawsuit filed by the Federal Trade Commission (FTC) alleging the company shared sensitive health information with third-party advertising platforms and engaged in deceptive billing and cancellation practices.
The FTC's complaint asserts that the company claims to maintain consumer privacy while sharing information and deceives users regarding its billing and cancellation policies. Following this news on July 29, 2026, Hims & Hers Health's stock price fell by 14.73%.
Investors who have experienced losses of over $100,000 and wish to discuss their legal options are encouraged to contact the law firm of Kahn Swick & Foti, LLC. Further details about the case and how to submit claims are available on the ClaimsFiler website.